After attending the session and submitting the attendance code, select Take course below to complete the evaluation and download CE certificate.
Learning Objectives
- Enhance Diagnostic Accuracy – Discuss the latest advancements in imaging, histopathology, and molecular profiling to improve the early and accurate diagnosis of rare brain tumors.
- Optimize Multidisciplinary Treatment Approaches – Review current treatment protocols, including surgery, radiation, and emerging targeted therapies, to develop individualized, evidence-based treatment plans for patients with rare brain tumors
- Advance Research and Collaboration – Identify gaps in current research, explore opportunities for clinical trials, and foster collaboration among neuro-oncologists, neurosurgeons, radiologists, and pathologists to improve outcomes in rare brain tumor management.
Session date:
06/02/2026 - 11:00am to 12:00pm EDT
Location:
Children's National Hospital - Virtual Platform
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™Children’s National Hospital designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCCChildren’s National Hospital will provide 1.00 Nursing Contact Hours for this Live activity.
- 1.00 ASWBAs a Jointly Accredited Organization, Children’s National Hospital is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.00 continuing education credits.
- 1.00 General
- 1.00 ParticipationSuccessful completion of this continuing education activity.
Faculty List:
Course Director(s)
Adriana Fonseca Sheridan, MD
has no relevant financial relationships to disclose at this time.

Facebook
X
LinkedIn
Forward